TrialPlastic and reconstructive surgery2020

DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Results from Each of Two Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Studies (SAKURA 1 and SAKURA 2).

Jean D Carruthers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.